United Devices Completes Phase 1 of Anthrax Project

3.57 billion molecules have been screened by computers around the world (including 3 from Kevin & Merrin) in hopes of finding a molecule suitable for treating advanced-stage Anthrax. In approximately 4 weeks time, the Internet community has come together with the help of Cambridge University, Intel and Microsoft to announce the following:

Preliminary indications are that we have narrowed the original pool of 3.57 billion molecules down considerably, having identified over 300,000 crude unique hits in the course of the project. This significantly reduces the next phase of the discovery process, in which the ranked hits will be further refined and analyzed, accelerating the overall time to availability of a treatment.

Dr. Graham Richards, Chairman of the Chemistry Department at Oxford and the Director of the Centre for Computational Drug Design, called the results "unprecedented," commenting, "Had we done this using traditional methods, it would have taken years instead of less than 4 weeks."

As one commercial puts it: "Behold, the power of cheese."

For those of you who want more information or would like to join in United Devices ongoing research to find a cure for cancer, click here. It costs nothing. Your computer does all the work when you're not using it, and you could help save millions of lives.

Congrats to Cambridge University, Intel, Microsoft, United Devices and the millions of project volunteers.

Share on FacebookTweet about this on TwitterShare on LinkedInEmail this to someone